Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
61
SGHT Quote, Financials, Valuation and Earnings
Last price:
$8.45
Seasonality move
:
9.54%
Day range:
$8.30 - $8.56
52-week range:
$2.03 - $8.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.73x
P/B ratio:
6.95x
Volume:
525.5K
Avg. volume:
263.8K
1-year change:
151.49%
Market cap:
$446.8M
Revenue:
$79.9M
EPS (TTM):
-$0.90
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$17.7M | -$0.26 | 5.73% | -31.35% | $7.85 |
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.24 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$17.8M | -$0.08 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$8.45 | $7.85 | $446.8M | -- | $0.00 | 0% | 5.73x |
|
ADGM
Adagio Medical Holdings, Inc.
|
$1.03 | $4.00 | $21.8M | 218.00x | $0.00 | 0% | 115.29x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$6.14 | -- | $5.9M | -- | $0.00 | 0% | 12.21x |
|
LAB
Standard BioTools, Inc.
|
$1.63 | $1.65 | $626.8M | -- | $0.00 | 0% | 4.80x |
|
LNSR
LENSAR, Inc.
|
$12.01 | $15.00 | $143.5M | -- | $0.00 | 0% | 2.41x |
|
MOVE
Movano, Inc.
|
$8.39 | $30.00 | $7M | -- | $0.00 | 0% | 12.70x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
38.76% | 1.013 | 22.54% | 8.65x |
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 2.155 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 2.628 | 67.05% | 0.29x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$17.2M | -$7.9M | -38.96% | -58.45% | -39.71% | -$8.9M |
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
Sight Sciences, Inc. vs. Competitors
-
Which has Higher Returns SGHT or ADGM?
Adagio Medical Holdings, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of --. Sight Sciences, Inc.'s return on equity of -58.45% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M -
What do Analysts Say About SGHT or ADGM?
Sight Sciences, Inc. has a consensus price target of $7.85, signalling downside risk potential of -7.1%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 288.35%. Given that Adagio Medical Holdings, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 ADGMAdagio Medical Holdings, Inc.1 0 0 -
Is SGHT or ADGM More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SGHT or ADGM?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or ADGM?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Adagio Medical Holdings, Inc. quarterly revenues of --. Sight Sciences, Inc.'s net income of -$8.2M is higher than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.73x versus 115.29x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.73x -- $19.9M -$8.2M ADGMAdagio Medical Holdings, Inc.115.29x 218.00x -- -$10.1M
-
Which has Higher Returns SGHT or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -269.38%. Sight Sciences, Inc.'s return on equity of -58.45% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About SGHT or INBS?
Sight Sciences, Inc. has a consensus price target of $7.85, signalling downside risk potential of -7.1%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1854.4%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is SGHT or INBS More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SGHT or INBS?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or INBS?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Sight Sciences, Inc.'s net income of -$8.2M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.73x versus 12.21x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.73x -- $19.9M -$8.2M INBSIntelligent Bio Solutions, Inc.12.21x -- $1.1M -$3M
-
Which has Higher Returns SGHT or LAB?
Standard BioTools, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -162.05%. Sight Sciences, Inc.'s return on equity of -58.45% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About SGHT or LAB?
Sight Sciences, Inc. has a consensus price target of $7.85, signalling downside risk potential of -7.1%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could fall by -4.91%. Given that Sight Sciences, Inc. has more downside risk than Standard BioTools, Inc., analysts believe Standard BioTools, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 LABStandard BioTools, Inc.1 2 0 -
Is SGHT or LAB More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock SGHT or LAB?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or LAB?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Sight Sciences, Inc.'s net income of -$8.2M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.73x versus 4.80x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.73x -- $19.9M -$8.2M LABStandard BioTools, Inc.4.80x -- $19.6M -$31.7M
-
Which has Higher Returns SGHT or LNSR?
LENSAR, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -25.94%. Sight Sciences, Inc.'s return on equity of -58.45% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About SGHT or LNSR?
Sight Sciences, Inc. has a consensus price target of $7.85, signalling downside risk potential of -7.1%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.9%. Given that LENSAR, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe LENSAR, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 LNSRLENSAR, Inc.0 2 0 -
Is SGHT or LNSR More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock SGHT or LNSR?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or LNSR?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Sight Sciences, Inc.'s net income of -$8.2M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.73x versus 2.41x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.73x -- $19.9M -$8.2M LNSRLENSAR, Inc.2.41x -- $14.3M -$3.7M
-
Which has Higher Returns SGHT or MOVE?
Movano, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -5036.25%. Sight Sciences, Inc.'s return on equity of -58.45% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About SGHT or MOVE?
Sight Sciences, Inc. has a consensus price target of $7.85, signalling downside risk potential of -7.1%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3475.69%. Given that Movano, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Movano, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 MOVEMovano, Inc.0 0 0 -
Is SGHT or MOVE More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SGHT or MOVE?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or MOVE?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Movano, Inc. quarterly revenues of $80K. Sight Sciences, Inc.'s net income of -$8.2M is lower than Movano, Inc.'s net income of -$4M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.73x versus 12.70x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.73x -- $19.9M -$8.2M MOVEMovano, Inc.12.70x -- $80K -$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
